A Study of Efficacy and Safety With the Transdermal Contraceptive System.

PHASE3CompletedINTERVENTIONAL

Enrollment

1,751

Participants

Timeline

Start Date

November 30, 1997

Study Completion Date

October 31, 1999

Conditions

ContraceptionFemale Contraception

Interventions

DRUG

norelgestromin + ethinyl estradiol

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236769 - A Study of Efficacy and Safety With the Transdermal Contraceptive System. | Biotech Hunter | Biotech Hunter